Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Invasive breast carcinoma: pathology and prognosis 

Invasive breast carcinoma: pathology and prognosis
Chapter:
Invasive breast carcinoma: pathology and prognosis
Author(s):

James Harvey

, Sue Down

, Rachel Bright-Thomas

, John Winstanley

, and Hugh Bishop

DOI:
10.1093/med/9780199215065.003.0010
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 September 2021

Invasive breast carcinoma- pathology and prognosis. This chapter provides an overview of the most common types of invasive breast cancer, and describes how various tumour factors influence overall prognosis. The main types of breast cancer are described, along with their specific characteristics. Common molecular factors such as oestrogen and HER2 receptor status are included in this section. The international system for staging of breast cancer allows comparison to be made between different units. Various prognostic tools and molecular profiling techniques are included which are of use when discussing individual prognosis with patients, these include NPI, Predict, Adjuvant!, oncotype DX and mammoprobe. Finally, future technologies are discussed, which will allow treatments to become more individualised.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.